Lead Clinical Laboratory Scientist (CLS) at BillionToOne

Union City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Molecular DiagnosticsIndustries

Requirements

California Clinical Laboratory Scientist License (required)
Experience in a high-complexity CLIA setting (preferred)
Strong understanding of molecular diagnostics and laboratory procedures
Driven and passionate individual

Responsibilities

Oversee and manage a team of Clinical Laboratory Scientists
Perform end-to-end processing of pregnancy blood samples for the UNITY NIPT
Ensure adherence to quality control procedures and regulatory guidelines
Maintain accurate records and documentation
Contribute to process improvements and efficiency
Support the development and implementation of new testing methodologies
Assist in training and mentoring laboratory personnel

Skills

Key technologies and capabilities for this role

California CLS LicenseCLIAMolecular DiagnosticsNIPTQuality ControlRegulatory ComplianceTeam ManagementProcess ImprovementLaboratory ProceduresBlood Sample Processing

Questions & Answers

Common questions about this position

What is the salary for the Lead Clinical Laboratory Scientist position?

This information is not specified in the job description.

Is this position remote or onsite?

The position is onsite.

What are the key requirements for this role?

A California Clinical Laboratory Scientist License is required, along with experience in a high-complexity CLIA setting preferred, strong understanding of molecular diagnostics and laboratory procedures, and being a driven and passionate individual.

What is the company culture like at BillionToOne?

This information is not specified in the job description.

How should I apply for this position?

Visit www.billiontoone.com to learn more about BillionToOne and the position, then submit your resume and cover letter through the company website.

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free